Lv6
2258 积分 2024-01-30 加入
Discovery of GDC-0077 (Inavolisib), a Highly Selective Inhibitor and Degrader of Mutant PI3Kα
1个月前
已完结
Paediatric Strategy Forum for Medicinal Product Development of Cyclin-Dependent Kinase Inhibitors in Children and Adolescents ACCELERATE in collaboration with the European Medicines Agency With participation of the Food and Drug Administration
1个月前
已完结
Conservation of the Chk1 Checkpoint Pathway in Mammals: Linkage of DNA Damage to Cdk Regulation Through Cdc25
4个月前
已完结
Improving the Therapeutic Index in Cancer Therapy by Using Antibody–Drug Conjugates Designed with a Moderately Cytotoxic Drug
5个月前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
6个月前
已完结
Expression of N-myristoyltransferase in Human Brain Tumors
6个月前
已完结
Association of FcγRIIIa-158V/F with systemic lupus erythematosus in a Chinese population
6个月前
已完结
A phase 1 clinical trial of ASG-5ME, a novel drug-antibody conjugate targeting SLC44A4, in patients with advanced pancreatic and gastric cancers
7个月前
已完结
Receptor Occupancy Imaging Studies in Oncology Drug Development
7个月前
已完结
OA08.05 Tusamitamab Ravtansine vs Docetaxel in Previously Treated Advanced Nonsquamous NSCLC: Results from Phase 3 CARMEN-LC03 Trial
7个月前
已完结
皖公网安备34019202002308